Cargando…

PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration

BACKGROUND: Moxibustion is a common intervention of Chinese medicine (CM). Systematic reviews (SRs) on moxibustion are increasing. Although the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement provides guidelines for SRs, the quality of moxibustion-related SRs is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xuan, Tan, Ran, Lam, Wai Ching, Cheng, Chung Wah, Yao, Liang, Wang, Xiao-Qin, Li, Si-Yao, Aixinjueluo, Qi-Ying, Yang, Ke-Hu, Shang, Hong-Cai, Wu, Tai-Xiang, Lyu, Ai-Ping, Bian, Zhao-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586688/ https://www.ncbi.nlm.nih.gov/pubmed/33100229 http://dx.doi.org/10.1186/s13643-020-01502-7

Ejemplares similares

WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
por: Zhang, Xuan, et al.
Publicado: (2020)

Reporting quality of systematic reviews with moxibustion
por: Tian, Ran, et al.
Publicado: (2020)

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
por: Page, Matthew J, et al.
Publicado: (2021)

Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
por: Welch, Vivian, et al.
Publicado: (2015)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
por: Liberati, Alessandro, et al.
Publicado: (2009)

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
por: Liberati, Alessandro, et al.
Publicado: (2009)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
por: Altman, Douglas G, et al.
Publicado: (2012)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
por: Altman, Douglas G., et al.
Publicado: (2012)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018)

Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
por: Hemming, Karla, et al.
Publicado: (2018)

Perspective: An Extension of the STROBE Statement for Observational Studies in Nutritional Epidemiology (STROBE-nut): Explanation and Elaboration
por: Hörnell, Agneta, et al.
Publicado: (2017)

Explanation and Elaboration Document for the STROBE‐Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology—Veterinary Extension
por: O'Connor, A.M., et al.
Publicado: (2016)

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
por: Calvert, Melanie, et al.
Publicado: (2021)

The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation
por: Xie, Runsheng, et al.
Publicado: (2020)

Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration
por: Cohen, Jérémie F, et al.
Publicado: (2021)

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
por: Vandenbroucke, Jan P, et al.
Publicado: (2007)

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
por: Chan, An-Wen, et al.
Publicado: (2013)

The standards of reporting trials in pets (PetSORT): Explanation and elaboration
por: Sargeant, Jan M., et al.
Publicado: (2023)

The PRISMA 2020 statement in Portuguese: updated recommendations for reporting systematic reviews
por: Galvão, Taís Freire, et al.
Publicado: (2022)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
por: Janssens, A Cecile JW, et al.
Publicado: (2011)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
por: Janssens, A. Cecile J. W., et al.
Publicado: (2011)

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
por: McShane, Lisa M, et al.
Publicado: (2013)

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
por: Cohen, Jérémie F, et al.
Publicado: (2016)

Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document
por: Pinnock, Hilary, et al.
Publicado: (2017)

Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
por: Percie du Sert, Nathalie, et al.
Publicado: (2020)

The SUPER reporting guideline suggested for reporting of surgical technique: explanation and elaboration
por: Zhang, Kaiping, et al.
Publicado: (2023)

CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
por: Hopewell, Sally, et al.
Publicado: (2008)

Bridging research integrity and global health epidemiology (BRIDGE) guidelines: explanation and elaboration
por: Alba, Sandra, et al.
Publicado: (2020)

CLARIFY 2021: explanation and elaboration of the Delphi-based guidelines for the reporting of yoga research
por: Moonaz, Steffany, et al.
Publicado: (2021)

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
por: Kwakkenbos, Linda, et al.
Publicado: (2021)

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews(*)
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

PRISMA 2020 and PRISMA-S: common questions on tracking records and the flow diagram
por: Rethlefsen, Melissa L., et al.
Publicado: (2022)

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
por: Moher, David, et al.
Publicado: (2010)

CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials
por: Grant, Sean, et al.
Publicado: (2018)

Moxibustion for the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis following PRISMA guidelines
por: Tan, Yumeng, et al.
Publicado: (2020)

The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration
por: Ogrinc, G, et al.
Publicado: (2008)

Data for the elaboration of the CIPROS checklist with items for a patient registry software system: Examples and explanations
por: Lindoerfer, Doris, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_84j35i1n4p60p0j04c3ogvsa66